A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell ...
State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...
No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...
15h
Clinical trial at Cleveland hospital leads to practice-changing precision prostate cancer therapy
A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman Cancer Center in Cleveland has identified the first validated predictive ...
A leading hospital in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding advanced cancer treatment options in a region ...
After a significant ruling from the Supreme Court of Appeal, prostate cancer patients in South Africa can continue to access the affordable generic drug Enzutrix, despite legal challenges from patent ...
Aga Khan University Hospital bets in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results